Lina Marie Rasmussen

Day 2 | 9th April

Unless pharma and med tech producers assess and plan for the risks, significant losses and adverse patient outcomes can be experienced
Supply-chain risks are unavoidable, but how can you minimise their disruptive effects?
What kinds of disruption are the pharma and medical device industry most vulnerable to?
What key technologies and processes are helping the industry to mitigate these risks and reduce vulnerabilities?

Check out the incredible speaker line-up to see who will be joining Lina.